DR. OGECHUKWU KINGSLEY EGINI M.D, MS
Prescription History 1770967754
Internal Medicine - Hematology in New Brunswick, NJ

Active since July 19, 2015PECOS EnrolledAccepts Medicare Assignment
195 LITTLE ALBANY ST, NEW BRUNSWICK, NJ 08901(732) 235-2465 Get Directions

NPPES record last updated: April 26, 2024. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Apr 26, 2024, Apr 11, 2024, Nov 14, 2023 and 2 more (5 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. OGECHUKWU KINGSLEY EGINI M.D, MS, an active Hematology specialist practicing in New Brunswick, NJ. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 11 documented patient claims. Among these therapy options, the most frequently utilized medication is Jakafi, which accounts for 11 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
11
Total Claims
11
30-Day Fills
Jakafi
Most Prescribed · 11 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by DR. OGECHUKWU KINGSLEY EGINI M.D, MS in 2024, with prescription volumes, average cost per fill, and NJ state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other NJ PrescribersVs. NJ Avg
JakafiRuxolitinib Phosphate11$12,561.70▼ below NJ avg▼ Less than typical

About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾

It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system).

In 2024, this provider wrote 11 Medicare prescriptions for Jakafi, about a third of the volume of the typical New Jersey prescriber of this medication (26.9). Medicare paid an average of $12,561.70 per fill, versus $16,657.85 statewide.

How often this provider prescribes it

This provider
11
NJ average
26.9

This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12,561.70
NJ average
$16,657.85

This provider's average cost per fill is below the NJ average for this medication.

11
30-Day Fills
standardized to 30-day supplies
330
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average NJ prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NJ average cost per fill.

About this data. The prescription history for DR. OGECHUKWU KINGSLEY EGINI M.D, MS is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology prescribing approach at this New Brunswick, NJ practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NJ prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.